Protein and Polycystic Ovary Syndrome (PCOS)

Part of paid clinical trials in Fayetteville, Arkansas.

Sponsor
University of Arkansas, Fayetteville
Study ID
NCT07158723
Status
Recruiting

Conditions

  • Polycystic Ovary Syndrome (PCOS)

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • Higher protein dietary pattern — OTHER
    Follow energy-restricted (10% calorie reduction), higher protein dietary pattern (1.6 g protein/kg body weight)
  • Calorie restriction — OTHER
    Follow energy-restricted (10% calorie reduction) dietary pattern for 16 weeks. No restrictions on macronutrient content.

Study Details

Polycystic ovary syndrome (PCOS) is a significant public health problem and is one of the most common hormonal disturbances affecting women of reproductive age. Women with PCOS are often insulin resistant, increasing their risk for cardiometabolic health problems (e.g., type 2 diabetes, heart disease, high blood pressure, sleep apnea, anxiety, depression, and stroke) especially if they are overweight. Lifestyle modifications, including dietary changes and regular physical activity, may alleviate metabolic dysfunction in women with PCOS and are often the first line of management for patients with PCOS. Several studies have identified protein as a key nutrient for regulation of energy balance, maintenance of skeletal muscle mass, and improving cardiometabolic health across the lifespan. However, the effect of increased protein intake (30% of total energy intake) on cardiometabolic health in women with PCOS has not been well-defined and mechanisms for these effects have not been identified. There is an evident need for well-designed, randomized controlled trials evaluating the efficacy of increased protein intake in women with PCOS on markers of cardiometabolic health. Preliminary data from collaborative projects with the investigators on this proposal suggest that increasing protein in the diet has the potential to improve markers of cardiometabolic health, potentially through improvements in body composition and/or changes in cortisol, energy metabolism, inflammation, and neurological regulators

Key Dates

Start date
Aug 1, 2025
Status verified
Sep 2025
Primary completion
Jun 30, 2027
Completion
Dec 3, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Active Comparator: Calorie restricted control
  • Active Comparator: Control and Protein
  • Active Comparator: Calorie restricted PCOS
  • Active Comparator: PCOS Protein

Primary Outcome Measure

Lean body mass [ Time Frame: 0 and 16 weeks. ]

Locations (2)

FacilityCityStateZIPSite coordinators
Center for Human NutritionFayettevilleArkansas72704
Jamie Baum, PhD
479-575-4474
Sydney Boudrey, MS, RDN
Jamie I Baum, PhD (PRINCIPAL_INVESTIGATOR)
Center for Human NutritionFayettevilleArkansas72704
Jamie Baum, PhD
479-575-4474
Sydney Boudrey, MS, RDN

Find similar trials in Fayetteville, AR

Related Studies